Gosset Ownership
Private
Therapeutic Areas
Stage
Other
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Nuvonis Technologies General Information
Nuvonis Technologies provides fully characterized, animal component-free GMP Vero cell banks and proprietary avian cell lines for use in viral vaccine and vector manufacturing. Their platforms are designed to reduce development timelines, improve quality, and minimize risks in product development. The company also offers technical support for process development, virus purification methods, influenza strain optimization, and reverse genetics. Their products are used by both small biotech firms and major pharmaceutical companies.
Contact Information
Primary Industry
Chemicals & Materials
Corporate Office
Vienna, Vienna
Austria
Austria
Drug Pipeline
No pipeline data available
Key Partnerships
Charles River Laboratories (GMP storage partner in the USA)
Nuvonis Technologies Funding
No funding data available
To view Nuvonis Technologies's complete valuation and funding history, request access »